Go Symbol Lookup
Loading...

Lightning Round: Monsanto, Juniper Networks, Pfizer and More

 Text Size  
Published: Thursday, 5 May 2011 | 7:01 PM ET
Lightning Round
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.

Monsanto : Cramer does not want to hedge his bets on this agricultural products company. The "Mad Money" host suggests buying DuPont instead, which has “a great seed division and a lot of great safety and health care businesses along side it.” He likes DuPont's 2.9 percent dividend yield, as well.

Royal Dutch Shell : Cramer is bullish on this oil and gas company, which he recommended buying after it reported last week.

“You’ll get that yield, you got the growth, you got an improved company," he said of RDS-A.

Juniper Networks : This stock only continues to fall and has "one of the worst charts" Cramer's ever seen, but he can't tell if it's bottoming because the company has great fundamentals. He praised CEO Kevin Johnson and recommended investors buy shares now.

Pfizer : Cramer is worried about Pfizer since Lipitor is going off patent soon. The pharmaceutical company’s stock is not as bad as it used to be, he said, but it is not enough to buy this stock.
















Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

 Print
Cramer makes the call on viewers' favorite stocks.
  Price   Change %Change
DD ---
JNPR ---
MO ---
PFE ---
RDSA ---

   
Comments

 

More Comments

 
 

Add Comments

 

Your Comments (Up to 1100 characters):

Remaining characters

Your comments have not been posted yet.

Please review your submission to make sure you are comfortable with your entry.

Your Comments:


                
            
            
        

Featured

Contact Mad Money

  • Showtimes

    Monday - Friday 6p | 11p ET
  • Cramer is host of CNBC's "Mad Money," and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.